Tonight: a congresswoman turns her miscarriage pain into getting one step closer to federal research, why everyone may need to move to one drink a day, and more.

— Meghan McCarthy

p.s. Our first trivia question awaits you at the bottom of this edition. Just how much do you know about pregnancy brain?

MISCARRIAGE PAIN IS BARELY STUDIED. A CONGRESSWOMAN IS TRYING TO CHANGE THAT.

Rep. Marie Gluesenkamp Perez told the House she lost a pregnancy at 11 weeks, and that the medication to pass the miscarriage left her in pain "worse than" delivering her son four years ago. Her amendment directing the NIH to study better pain management for miscarriage was passed unanimously. The issue is complicated — Republicans want to take away telehealth prescribing for the abortion pill (despite its record of safe use) and may see this as bolstering their argument. But the congresswoman is focused on a common refrain in women’s health: why doesn’t our pain matter?

OB-GYNS BREAK WITH THE CDC ON VACCINES (FOR OBVIOUS REASONS)

It’s not a shock, but for the American College of Obstetricians and Gynecologists issued its own immunization schedule for pregnant and postpartum patients instead of following CDC guidance (or lack thereof). This comes after the agency replaced its COVID-in-pregnancy recommendation with "no guidance" last year. Endorsed by 13 medical groups, ACOG urges flu, Tdap, COVID, and RSV protection at any point in pregnancy or breastfeeding. ACOG said it withdrew from the CDC's vaccine committee this year over "concerns about recent changes that undermine the committee's scientific integrity."

NO AMOUNT OF ALCOHOL IS PROTECTIVE. AND THE GUIDELINES FOR MEN AND WOMEN ARE CONVERGING.

A new analysis found alcohol's health risks start climbing at relatively low levels for both men and women, with almost identical thresholds for increased mortality risk. Researchers estimated that drinking more than about 6.5 drinks per week for men and 7 drinks per week for women pushed lifetime alcohol-related death risk above 1 in 1,000, while risks exceeded 1 in 100 at roughly 8.5 drinks per week for both sexes. The findings challenge the long-standing U.S. dietary guidelines that allow men up to two drinks per day but women only one. The authors argue future guidance should recommend no more than one drink daily for everyone.

WHAT NEW MOTHERS EXPECT OF THEIR SLEEP MAY SHAPE WHAT THEY GET

Among around 430 pregnant women, those who expected the worse sleep after delivery ended up actually having worse sleep, measured by both wrist trackers and self-report. And that is after researchers accounted for prior sleep problems and psychiatric history. Postpartum anxiety deepened the effect. Researchers say sleep beliefs and anxiety, unlike most postpartum risk factors, could be addressed during pregnancy, before the sleepless months arrive.

MENOPAUSE IS HITTING WOMEN RIGHT WHEN THEY'D REACH THE TOP

Menopause arrives around 52, and the average CEO is hired at 54. Fast Company reports that senior women said menopause is quietly pushing them out: lost confidence, a blazer thrown off mid-boardroom meeting, careers abandoned. Only 11% of companies offer menopause benefits, the same share of Fortune 500 CEOs who are women. Half of women say their workplace never discusses it at all.

Tonight: Americans suddenly find birth control less acceptable, the FDA's progress against the abortion pill, what your iPhone now knows about menopause, and more.

— Meghan McCarthy

p.s. Please check out our new poll below! We will be asking some fun trivia questions in the future…email [email protected] if you’ve got a good one to share.

AMERICANS ARE COOLING ON BIRTH CONTROL

The share of Americans who say birth control is morally acceptable fell to 83%, a record low since Gallup started asking in 2012. Last year, approval was 90%. Independents drove the slide, with their acceptance down 11 points in a single year. Birth control has ranked as the single most morally acceptable behavior Gallup tracks every year it's been on the list, which is what makes the dip worth watching.

THE FDA REOPENS MIFEPRISTONE'S SAFETY QUESTION

The FDA launched the safety review of mifepristone they had promised for months, a drug that accounts for about two-thirds of U.S. abortions. Former FDA Commissioner Marty Makary had allegedly said the study would be delayed because it would be unpopular to release before the midterm elections. The agency still says the drug is safe and effective when used as directed, and HHS insists it has been reviewing the drug's safety rules for months, disputing that anything new just began. Preliminary results are expected in July; the full review likely won't land until after the November midterms.

YOUR PHONE MAY FLAG PERIMENOPAUSE?

At its developer conference Monday, Apple said the Health app will start alerting women 40 and older when their logged cycle patterns suggest perimenopause, then steer them toward symptom tracking and educational material to bring to a doctor. It's the company's deepest move into women's health since it launched period tracking in 2019.

A BREAST-CANCER SIGNAL IN THE WEIGHT-LOSS DRUGS

A study found that around 110,000 women ages 45 to 80 carrying extra weight were 30% less likely to be diagnosed with breast cancer while taking GLP-1 drugs like Ozempic and Wegovy. The study was observational, so it can't prove the drugs deserve the credit, and the team is now standing up a clinical trial to test the link directly. Obesity after menopause is a known breast cancer risk factor, but researchers suspect the drugs' effects on weight *and* inflammation may be doing the work.

BEING FEMALE MAY NOT BE THE AFIB STROKE RISK WE THOUGHT

For years, simply being a woman has counted as a stroke risk factor in atrial fibrillation, the most common heart-rhythm disorder. That earned female patients an automatic point towards being put on blood thinners. A Tulane analysis of roughly 950,000 patients found that may be too blunt: under age 75, women and men faced essentially the same one-year stroke risk, with the added risk showing up mainly in women 75 and older. Because blood thinners carry real bleeding risks, the authors argue the call should be individualized and point to a newer scoring system that drops sex as a standalone factor.

Here are the most interesting items we saw this week in women's health:

🤰 Tylenol is still safe in pregnancy, whatever the president said. After Trump and RFK Jr. warned against acetaminophen without strong evidence, the Society for Maternal-Fetal Medicine reaffirmed it as the first-line treatment for pain and fever, finding no causal link to autism or ADHD. Two in three pregnant women use it, and untreated first-trimester fever is tied to birth defects and miscarriage.

🩺 Hormone therapy works. Almost no one is taking it. Use among women 40 and older HRT use fell to under 2% by 2023, and just 3.5% of women ages 50 to 59 (the group most likely to benefit), per a Mayo Clinic analysis. The evidence shows it's safe and effective for many women under 60, and recent changes to “black box” warnings could increase usage.

📊 Real money is finally flowing to midlife health. Melinda French Gates committed $215 million to women's reproductive and midlife health, her first major bet on perimenopause and menopause. She partnered with the Menopause Society to expand training for the clinicians most women struggle to find.

TOP CLICKED STORIES THIS WEEK

• NC GOP lawmaker removes name from anti-abortion bill after social media outcry // NC Newsline
  

• Ferguson signs executive order to support working women experiencing menopause in WA // KUOW
  

• Financial, Psychological Burden of Abortion Care in US Raises Calls for Expanded Insurance // AJMC
  

• Hormone therapy use for menopause declines despite proven benefits, study finds // Mayo Clinic News Network
  

• SMFM Reaffirms Acetaminophen as First-Line Medication for Treating Pain and Fever During Pregnancy // Society for Maternal-Fetal Medicine
  

• OPTIMA: Genetic Test–Determined Chemo Is Noninferior to Chemo + Endocrine Therapy in Selected Patients With Early Breast Cancer // ASCO Daily News

Tonight: a $215 million push for menopause care, the proven treatment almost no one was using in 2023, and more.

MELINDA GATES BETS $215 MILLION ON MIDLIFE Gates announced $215 million in new funding for women's reproductive and midlife health, her first major investment focused on perimenopause and menopause. It is part of a broader $600 million women's health commitment her organization has made over the next two years. She's partnering with the Menopause Society to expand menopause training in OB-GYN residencies, primary care, and nursing programs, addressing a gap that leaves many women struggling to find clinicians who understand the transition.

ILLINOIS PASSES A SHIELD FOR ABORTION RECORDS Illinois lawmakers passed the Reproductive Health Privacy Act, which allows patients to block abortion care and gender-dysphoria diagnoses from the electronic records hospitals routinely share across state lines. Sponsors said some patients who traveled to Illinois for abortions were later dropped by home-state physicians after the procedure appeared in their charts. The records aren't deleted, only shielded from out-of-state access without patient consent. Gov. JB Pritzker has said he'll sign the bill.

HORMONE THERAPY WORKS. HARDLY ANYONE WAS TAKING IT IN 2023. Hormone therapy for menopause fell from more than 4% of women 40 and older in 2007 to under 2% in 2023. Among women ages 50 to 59 (the group most likely to benefit), only about 3.5% used it, according to a Mayo Clinic analysis. Usage remains near its lowest point since the 2002 Women's Health Initiative study triggered widespread fears about hormone therapy, despite strong evidence that treatment is safe and effective for many women under 60. The FDA recently removing the black box warning on HRT, which may increase use in more recent years.

THE FERTILITY AND ALCOHOL MESSAGE ISN'T COMPUTING. Ninety percent of women of childbearing age know drinking during pregnancy is unsafe, up from 82% a year earlier. But only about two-thirds know they should stop drinking before conception, according to an Annenberg survey of around 1,600 adults. The gap matters: federal data show more than one in eight pregnant adults reported drinking in the past month.

LIFT THE MALPRACTICE CAP, LOSE THE MIDWIFE? After Georgia and Illinois removed caps on malpractice damages, physician-attended births in rural counties rose by nearly 3 percentage points even though overall birth rates didn't change, according to a Harvard analysis of more than 20 million births. The likely explanation is liability risk: hospitals facing larger potential lawsuits appear more likely to favor physician-attended deliveries over midwife-attended ones. Researchers found no corresponding change in C-sections, inductions, or infant outcomes, suggesting the shift reflected risk management rather than better care.

Tonight: the NC personhood bill's IUD problem, Washington on menopause at work, and more.

— Meghan McCarthy

NORTH CAROLINA'S PERSONHOOD BILL HAS AN IUD PROBLEM

North Carolina Republicans filed a constitutional amendment in May that would define life from the moment of fertilization and grant anyone the right to use “deadly force” in defense of human life. A labor and delivery nurse's viral video — 193,000 likes — argued that IUDs, which prevent implantation rather than fertilization, could expose users to criminal liability under the bill. The backlash was significant enough that one of the two primary sponsors removed his name; Rep. Keith Kidwell of Beaufort is now the sole sponsor.

WASHINGTON GOVERNOR ORDERS STATE AGENCIES TO ACCOMMODATE MENOPAUSE SYMPTOMS

Washington is the latest state to require agencies to accommodate employees with menopause symptoms, including considerations like flexible scheduling, temperature control, and access to cold water among the measures. A state commission has a year to develop guidance for both state agencies and private employers; a progress report is due to the governor by April 2027. Rhode Island enacted a broader mandate in 2025 covering all employers statewide.

TWO IN THREE PREGNANT WOMEN TAKE TYLENOL. OB SPECIALISTS SAY KEEP TAKING IT.

After Trump and RFK Jr. warned earlier this year against acetaminophen in pregnancy without strong evidence, the Society for Maternal-Fetal Medicine reaffirmed June 1 that it remains the first-line treatment for pain and fever. SMFM's review found no causal link between prenatal acetaminophen and autism or ADHD; RFK Jr. has since walked back to calling the evidence merely "suggestive." Two in three pregnant women use the drug at some point; untreated first-trimester fever is linked to birth defects and miscarriage.

SOME HIGH-RISK BREAST CANCER PATIENTS MAY NOT NEED CHEMO AFTER ALL

A trial for over 4,000 women found that 68% of those classified as clinically high-risk for early breast cancer had low genomic scores and could safely skip chemotherapy, doing well on hormone therapy alone. Results were presented at the ASCO annual meeting, and the trial offers the strongest evidence yet that women may be pushed toward chemotherapy their tumor biology doesn't require.

FOUR IN TEN ABORTION PATIENTS HIT A CATASTROPHIC SPENDING THRESHOLD

Out-of-pocket abortion costs vary so widely that 42% of patients exceed what researchers classify as the “catastrophic spending threshold,” i.e. more than 40% of household income after basic needs. The analysis tracked direct care costs plus travel, childcare, and lost wages. For patients who crossed state lines, 65% hit the catastrophic mark.

Tonight: the preventive care panel RFK is messing around with, giving money to pregnant women helps babies, and more.

— Meghan McCarthy

THE TASK FORCE THAT MAKES YOUR MAMMOGRAM FREE HASN'T MET IN THREE MONTHS

RFK Jr. fired both vice chairs of the U.S. Preventive Services Task Force last week, an independent panel that determines what preventive care health insurance must cover at no cost under the ACA. That includes everything from mammograms, breast and cervical cancer screenings, birth control, and depression screenings. The task force has not convened since March and has no meetings scheduled. Even worse, former members said the administration suppressed a completed recommendation endorsing at-home HPV self-testing as an alternative to the Pap smear.

THE U.S. JUST ADDED A PAID-LEAVE SCORE FOR NEW MOMS. IT'S AN F.

The Policy Center for Maternal Mental Health at George Washington University graded all 50 states on their maternal mental health infrastructure for the fourth consecutive year, adding a "parental support" domain in 2026 that immediately dragged the national grade to an F. Paid leave and childcare access were absent or inadequate in 31 states, which scored less than one star out of five; Maine led with 3.5 stars. One in five new mothers in the U.S. experiences a maternal mental health condition; untreated, these disorders have lasting effects on women's well-being, family stability, and child development.

IN THE WORLD'S LARGEST BREAST CANCER DATASET, ONE PATIENT IS NATIVE AMERICAN

The Cancer Genome Atlas is the world's largest breast cancer database with more than a thousand patients. But only one of them is Native American, which means today's targeted treatments were calibrated on data from other populations. A team at Notre Dame compared 17 Native American tumor samples to nearly 700 from white women and found differences at every level studied: which genes mutated, how tumors evaded immune defenses, how DNA was organized. Native American women have lower breast cancer incidence than white women but higher mortality rates — the researchers say these biological differences may help explain why.

TURNS OUT, GIVING PREGNANT WOMEN CASH WORKS

Flint, Michigan's Rx Kids program gave pregnant women $1,500 mid-pregnancy and $500 a month through the baby's first year, with no restrictions on how families spent it. The results showed a cut in NICU admissions by 29% and low birthweight rates dropped by over 4 percentage points. The study tracked about 4,500 births across similar Michigan cities. The program also reduced evictions, increased prenatal care visits, and drove a 32% drop in child maltreatment allegations. The results offer the most comprehensive real-world evidence yet that unconditional cash in the perinatal period outperforms most targeted interventions.

TRUMP'S HEALTH AGENDA DOESN’T DELIVER (YET) FOR ABORTION HATERS

Anti-abortion groups that helped elect Trump are now openly breaking with his administration, frustrated that MAHA pet projects like food dyes, dietary guidelines, and vaccine recommendations have crowded out moves to restrict mifepristone. The FDA recently approved a new mifepristone generic rather than rolling back access; the agency's top two officials, both targets of sustained anti-abortion pressure, departed in the past month. The White House's response to the movement so far is Moms.gov, a directory of crisis pregnancy centers.

Tonight: denied lifesaving care in Arkansas, the postpartum cliff, and more.

— Meghan McCarthy

SHE CALLED THE GOVERNOR'S OFFICE. ARKANSAS STILL WOULDN'T HELP.

ProPublica's Kavitha Surana documents how Emily Waldorf, a 38-year-old physical therapist at the Arkansas hospital where she had worked for six years, spent five days being denied care for an inevitable miscarriage. During that time her cervix was open to a potentially deadly infection, and despite meeting with the hospital CEO, calling the governor's office, and retaining a lawyer, she was refused care in her home state. She had to be transferred by ambulance to Kansas, she nearly died when her placenta failed to detach and she lost a liter of blood. The investigation surfaces a new gap: unlike Texas, Arkansas has issued no guidance telling doctors they can legally induce miscarriages without waiting for sepsis to set in.

THE BABY GETS SEVEN CHECKUPS. THE MOTHER GETS ONE.

In an essay in the New York Times, Sejal Hathi, director of the Oregon Health Authority and a Stanford physician, describes assembling her own postpartum care after a third-degree tear and separated abdominal muscles that made lifting her infant difficult. Her specialist OB discharged her at six weeks, her clinic had too booked for new postpartum patients, and her primary care physician said recovery was outside her scope. As Hathi put it: “Beyond the first few weeks after delivery, no single clinician owns accountability for the mother’s recovery and well-being. Her baby will see a pediatrician seven or more times in the first year of life. Whether the mother sees a doctor will depend largely on whether something goes wrong.”

TRUMP PROMISED TO COVER IVF. DON'T WAIT FOR IT.

Last week, the Trump administration proposed a rule letting employers voluntarily offer standalone IVF benefits with a $120,000 lifetime cap — no mandate, no financial incentive for employers to sign on. Experts are unconvinced: "Do not delay your treatment thinking there's going to be a benefit from this policy anytime soon," said Sean Tipton of the American Society for Reproductive Medicine. A single IVF cycle runs $25,000 to $35,000; only 30 percent of employers currently cover it; Trump's 2024 campaign had promised the government would pay.

THE PERIMENOPAUSE CONTENT BOOM HAS A SIDE EFFECT: UNINTENDED PREGNANCIES.

Experts interviewed by the Guardian warn that perimenopause content on social media is sending some women in their 30s and 40s to demand HRT for insomnia while stopping contraception, a combination producing unintended pregnancies. "I work in an abortion service and we're seeing more women over 35 now who believe themselves to be menopausal and are gobsmacked when they become pregnant," said Dr. Paula Briggs, a sexual and reproductive health consultant. The British Menopause Society's chair is direct: if you're still having regular periods, you're not perimenopausal, and contraception is needed until menopause is confirmed or age 55.

WHAT HAPPENS TO THE FEMALE BRAIN WHEN ESTROGEN DISAPPEARS

A Northwestern Medicine preclinical study is the first to show that estrogen loss after menopause alters the extracellular matrix (molecular scaffold between certain brain cells) in women but not in men. The ECM makes up about 20 percent of brain volume and helps cells communicate; its breakdown in aging females may help explain why two-thirds of Alzheimer's patients are women. "Once memory is gone, it's gone," said Serdar Bulun, the study's senior author and chair of obstetrics and gynecology at Northwestern Feinberg.

Tonight: a weight loss drug just posted numbers associated with bariatric surgery, what 198 proteins in your blood have to do with your period, and more.

— Meghan McCarthy

WOMEN'S HEALTH GETS 20 CENTS ON THE RESEARCH DOLLAR

Only 20% of program funding across the ten conditions analyzed by the World Economic Forum targets women specifically, and 59% of that goes to just two: ovarian cancer and menopause. For conditions that hit women harder or differently, including heart disease and anxiety, fewer than 3% of clinical trials carry any women-specific focus. Anxiety disorders illustrate the translation gap: 112 pipeline programs identified, four products launched in the past decade.

THE NEXT WEIGHT LOSS DRUG JUST HIT NUMBERS ASSOCIATED WITH BARIATRIC SURGERY

Eli Lilly's retatrutide — a GLP-1 that also hits two additional receptors — posted results showing over 45% of participants reached at least 30% weight loss, a threshold long associated with bariatric surgery. Participants who took the drug for two years lost an average of 85 pounds. Women already use GLP-1 drugs at roughly twice the rate of men which makes the results particularly consequential for women's health.

THE MENSTRUAL CYCLE LEAVES A PROTEIN FINGERPRINT IN YOUR BLOOD

A Nature Medicine study analyzed blood plasma from around 2,800 women and identified 198 proteins that rise and fall in distinct patterns across the menstrual cycle — extending well beyond reproductive hormones into immune, vascular, and metabolic pathways. Several of those proteins overlap with endometriosis, fibroids, and abnormal uterine bleeding. Researchers also developed a 75-protein score capable of predicting menstrual cycle phase from a single blood draw, with potential implications for how clinical trials account for cycle timing and how these common, chronically underdiagnosed disorders get identified earlier.

CREATINE IS THE MENOPAUSE SUPPLEMENT OF THE MOMENT. DOCTORS ARE LESS SURE.

Creatine has become the supplement of the moment for women in perimenopause and menopause, with influencers claiming it fights muscle loss and brain fog. The New York Times found that most creatine research has been done in men and a 2025 meta-analysis couldn't draw conclusions on its effects in middle age due to insufficient data. The Cleveland Clinic's medical director for women's comprehensive health described the evidence in women as "quite weak." Most physicians interviewed won't recommend it but won't fight a patient who wants to try: it's safe, inexpensive, and — per the experts — has to be paired with resistance training to do anything for muscle mass at all.

BIRTH CONTROL IS OTC NOW. YOUNG WOMEN STILL DON'T KNOW HOW IT WORKS.

Since 2024, birth control pills are available over the counter in the U.S. — no prescription needed. A University of Mississippi School of Pharmacy survey of women aged 16 to 24 found they have only moderate knowledge about how pills prevent pregnancy and what the side effects are, with rural women faring worse due to pharmacy closures and fewer OBGYNs. The study's author flags AI chatbots and platforms like ChatGPT as an unreliable substitute for a provider conversation — at a moment when that's exactly where many young women are going for answers.

Tonight: abortion bans are changing miscarriage care, how biology might play a role in PMDD and psychiatric conditions, and more.

— Meghan McCarthy

WHAT ABORTION BANS ARE DOING TO MISCARRIAGE CARE

States with abortion bans at or before six weeks have also changed how miscarriages get treated, a JAMA study of tens of thousands of privately insured patients found. Women in ban states were less likely to receive the gold standard mifepristone-misoprostol regimen and 14 points more likely to be given misoprostol alone, a less effective option with greater side effects. The study, the first national look at this connection, excludes Medicaid patients, which means the actual scope is likely larger. The broader point: abortion bans are no longer just shaping abortion access; they’re reshaping routine pregnancy care for women who very much wanted to stay pregnant.

YOUR PMDD AND YOUR ANXIETY ARE DRIVING EACH OTHER

Women with premenstrual disorders face roughly double the lifetime risk of developing depression, anxiety, ADHD, or bipolar disorder, and the relationship runs both ways: prior psychiatric diagnoses roughly double the risk of later developing PMDD or PMS, a JAMA Network Open analysis of 3.6 million Swedish women found. Researchers tracked records from 2001 to 2022. The two-way pattern suggests the conditions share underlying biology rather than merely co-occurring by chance. The bigger implication is that PMDD still gets treated culturally as “bad PMS” when the data increasingly points to it being deeply intertwined with serious psychiatric and neurodevelopmental conditions.

THE MENOPAUSE SLEEP SYMPTOM THAT MISSES SCREENING

A nationally representative survey of 1,200 U.S. women, presented at the ACOG annual meeting, found that 75 percent of those with menopausal symptoms reported sleep problems, compared with about half of women without symptoms. Sleep disorders rarely come up at menopause appointments, even though untreated sleep disruption compounds other menopausal health risks, including cardiovascular disease and depression.

FOR THE HIGHEST-RISK C-SECTIONS, A DRUG THAT CUTS HEMORRHAGE RATES

A multicenter Chinese randomized trial of around 1,700 women with placenta previa found that giving tranexamic acid at the time of cesarean delivery cut postpartum hemorrhage rates from 35 to 30 percent, a statistically significant though modest reduction, per the BMJ study. Placenta previa, in which the placenta partially or fully covers the cervix, puts women at elevated hemorrhage risk; postpartum hemorrhage is the leading cause of maternal death worldwide.

THE FDA DOOR NOW WIDE OPEN FOR ABORTION OPPONENTS

Anti-abortion groups spent months calling for FDA Commissioner Marty Makary's firing over his slow-walking a mifepristone “safety” review, and his exit this week gives them a new shot at a successor willing to restrict the drug's telehealth approval. His departure is also a loss for menopause advocates. Makary championed expanded hormone therapy access, and the FDA removed black box warnings from estrogen treatments during his tenure.

Here are the most interesting items we saw this week in women's health:

🩺 The Supreme Court let the abortion pill stay on telehealth — for now (again). The court ruled Thursday that mifepristone can continue being prescribed via telehealth while a Louisiana challenge moves through lower courts. Two conservative justices dissented, calling the result a "perpetration of a scheme" against the court's decision to allow states to ban abortion.

💊 Postpartum depression peaks around two weeks after birth. A Lancet Psychiatry meta-analysis of around 2 million women across 90 countries found the highest prevalence of major depressive disorder comes earlier than most standard screening starts.

🔬 PCOS is officially being renamed PMOS. A global group of 56 organizations and The Lancet agreed to rename polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, finally reflecting the metabolic and hormonal disease it actually is. The "cysts" were never cysts. They're arrested follicles.

TOP CLICKED STORIES THIS WEEK

Healthy Moms, Healthy Babies America Launches National Campaign to Cut U.S. Maternal Mortality in Half Within Five Years — Heartland Forward

New Gov't Website Will Help CPCs Collect Data On Pregnant Women — Abortion, Every Day

The Men Who Want Women to Be Quiet — The Atlantic

Cardiovascular Health Characterization Using Life's Essential 8 Score in Perimenopausal Women: An Analysis of the National Health and Nutritional Examination Survey — Journal of the American Heart Association

How to Improve Your Bone Health — Vogue

The global prevalence of major depressive disorder during the peripartum period: a systematic review and meta-regression — The Lancet Psychiatry

Risk of congenital anomalies among infants of patients with endometriosis: a population-based cohort study — CMAJ